| Company Name: |
ACROBiosystems |
| Tel: |
13121935750 |
| Email: |
jiaxin.zhao@acrobiosystems.com |
|
| Product Name: | HUMAN FGF-5 | | Synonyms: | Anti-FGF5 (C-terminal) antibody produced in goat;HUMAN FIBROBLAST GROWTH FACTOR 5;HUMAN FGF-5;FIBROBLAST GROWTH FACTOR 5;FIBROBLAST GROWTH FACTOR-5, HUMAN;FGF-5;FGF-5, HUMAN;RECOMBINANT HUMAN FGF-5 | | CAS: | | | MF: | | | MW: | 0 | | EINECS: | | | Product Categories: | | | Mol File: | Mol File | ![HUMAN FGF-5 Structure]() |
| | HUMAN FGF-5 Chemical Properties |
| storage temp. | −20°C | | form | lyophilized powder |
| | HUMAN FGF-5 Usage And Synthesis |
| Description | FGF5 Human Recombinant produced in E.coli is a single, non-glycosylated polypeptide chain having containing 252 amino acids and having a molecular mass of 27.7kDa.
The FGF-5 is purified by proprietary chromatographic techniques. | | Source | Escherichia Coli | | Background | Fibroblast Growth Factor-5 (FGF5) belongs to the FGF family of mitogenic peptides. In vitro, rhFGF5 is a mitogen for Balb/3T3 fibroblasts and bovine heart endothelial cells. FGF5 is also a major muscle-derived survival factor for cultured spinal motoneurons. In vivo, FGF5 is assumed to play central roles in both embryology and neurobiology. Developmentally, FGF5 mRNA is originally found in the embryoblast followed by the lateral somatic mesoderm, where it may play a part in angiogenesis, as well as the myotomes cranial to the tail region, where it may delay terminal myoblast differentiation during cell migration. |
| | HUMAN FGF-5 Preparation Products And Raw materials |
|